Hybrid Pharmacophore Design and Synthesis of Naphthalimide– Benzimidazole Conjugates as Potential Anticancer Agents

Author(s): Ahmed Kamal, Pogula Praveen Kumar, Mohammed Naseer Ahmed Khan, Bobburi Naga Sheshadri, Naga Sheshadri

Journal Name: Letters in Drug Design & Discovery

Volume 12 , Issue 5 , 2015

Become EABM
Become Reviewer

Graphical Abstract:


Naphthalimide-benzimidazole conjugates were prepared using two different types of spacer units; either a simple alkane chain or a substituted piperazine moiety with variable alkyl side chains. Each set of conjugates was evaluated for their in vitro anticancer activity, and compounds 14a, 14b and 20c were found to exhibit significant activity against a number of cancer cell lines. In particular, compound 14a showed remarkable anticancer activity with GI50 values of 0.02 μM and 0.49 μM against central nervous system (SNB-75) and leukemia (K-562) cell lines, respectively. Compound 14b showed noticeable activity against melanoma (MAME-3M) cell line with GI50 value 0.09 μM. Compound 20c also displayed selectivity against leukemia cell lines with GI50 values up to 0.21 μM as well as appreciable broad-spectrum cytotoxicity.

Keywords: Benzimidazole, conjugates, cytotoxicity, naphthalimide, piperazine.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [374 - 384]
Pages: 11
DOI: 10.2174/1570180811666140915221955
Price: $65

Article Metrics

PDF: 30